Johnson & Johnson Hit by $4.7 Billion Jury Verdict in Ovarian Cancer Case

Johnson & Johnson (JNJ) was ordered on Thursday by a jury in Missouri to pay $4.69 billion in damages to 22 women who claimed the company's baby powder contained asbestos that caused their ovarian cancer.

The jury award in the case included $550 million in compensatory damages and $4.14 billion in punitive damages, according to a statement from the attorneys representing the plaintiffs.

Johnson & Johnson shares fell $3.01, or 2.36%, in after-hours trading.

The company faces more than 9,000 cases over body powders containing talc, according to its latest quarterly filing with the SEC.

In a statement, the company said it would appeal the verdict, "which was the product of a fundamentally unfair process that allowed plaintiffs to present a group of 22 women, most of whom had no connection to Missouri, in a single case all alleging that they developed ovarian cancer."

More from Investing

Stocks Drift Lower as Trade War Jitters Offset Earnings Season Optimism

Stocks Drift Lower as Trade War Jitters Offset Earnings Season Optimism

The Recent Pullback in the Defense Sector Provides a Buying Opportunity

The Recent Pullback in the Defense Sector Provides a Buying Opportunity

Futures Lower on Trade Worries and 4 Other Stories to Watch Thursday

Futures Lower on Trade Worries and 4 Other Stories to Watch Thursday

Video: What to Expect From Microsoft's Earnings Thursday

Video: What to Expect From Microsoft's Earnings Thursday

UnitedHealth Could Strike Deal for Tenet's Conifer Subsidiary: Reports

UnitedHealth Could Strike Deal for Tenet's Conifer Subsidiary: Reports